Cynergy™

World-class, dual-wavelength vascular workstation proven safe and effective, including for pediatric use.1

Advanced technology, efficacious outcomes

The Cynergy workstation treats vascular and pigmented lesions more effectively than conventional, single-wavelength platforms. With both high-powered 585nm pulsed dye and 1064nm Nd:YAG wavelengths, our proprietary MultiPlex technology enables the sequential emission of the two wavelengths from one delivery system for optimised clinical effectiveness. It is able to treat:

  • Facial and leg telangiectasias
  • Spider veins
  • Hemangiomas
  • Port-wine stains
  • And more

 

The science of MultiPlex™

Sequential emission means that Cynergy’s sub-purpuric, pulsed-dye laser fires milliseconds before the Nd:YAG laser. This first pulse converts oxy-hemoglobin to methemoglobin, which increases the absorption coefficient for the Nd:YAG wavelength by 300–500%.2,3

Next, the Nd:YAG laser fires and is more effectively absorbed by the converted target, enabling reduced Nd:YAG fluence for enhanced patient safety. Since greater penetration depth is achieved, outcome results are also optimised.

By emitting dual wavelengths, Cynergy provides safe and effective results in less time than single-wavelength systems. For your patients, that means greater comfort and satisfaction. For you, that means greater patient throughput.

#

Cynergy Brochure

Learn more about the Cynergy device

Before & After

FAQ

What side effects can occur?

The following side effects can occur when treating with the Cynergy laser:

  • Scarring, though rare, can occur following any laser procedure.
  • Blistering during treatment may be an indication of sun exposure or an excessive fluence
    setting for the skin type. Blistering can occur during the first three days following the
    laser procedure. Blistered areas should be treated with care, keeping the area moist with
    an ointment until area has healed.
  • Papules, similar to hives, may develop in some patients. This irritation usually subsides in
    a few hours. Scaling or scabbing of the skin is most often associated with higher energy
    settings. The incidence of these changes diminishes when the treatment energy is reduced.
  • Hyperpigmentation (darkening of the treated area) or hypopigmentation (excessive
    lightening of the treated area) may occur. Reported pigmentary changes have been
    transient.
  • Punctate depressions are small minute spots of depression that may occur posttreatment if
    laser fluences are too high or if a significant amount of overlapping technique was
    utilized during treatment. In most cases, punctate depressions will fill in naturally during
    the healing phase.

Atrophic changes are textural surface changes have occasionally been noted in patients
that have not been compliant with posttreatment skin care instructions. Surface changes
have usually involved small areas of excoriation. Incidence of hypertrophic scarring has
never been reported.

Hair Removal:

  • Pustules or pimples may develop in the first few days following treatment. The affected
    area should be kept clean and treated with care.

Facial Skin Treatment:

  • Pustules or pimples may develop in the first few days following treatment. The affected
    area should be kept clean and treated with care.

Veins:

  • Patients will experience some temporary reddening of the skin around the treatment site.

 

 

1 Geronemus R J Dermatol Surg Oncol. 1993;19:303–310.
2 Barton JK, et al. Optical and magnetic resonance changes in photothermally coagulating blood. Proceedings of SPIE 2002; 4609:10-19.
3 Kuenstner JT, Norris KH. Spectrophotometry of human hemoglobin in the near infrared region from 1000 to 2500 nm. Near Infrared Spectrosc 1994;2:59-65.

©2019 Hologic, Inc. Cynosure, Cynergy, and MultiPlex are trademarks and/or registered trademarks of Cynosure, LLC. Hologic, Inc. owns exclusive rights to photography. Use of photography without written permission of Hologic is prohibited.

Like all medical procedures, not all patients are suitable for the treatment. A qualified practitioner is solely responsible for evaluating each subject’s suitability to undergo treatment and for informing those being treated about any risks involved with the treatment, pre-and postoperative care, and any other relevant information. Individual results may vary and are not guaranteed.

Events

Loading
Loading events ...

Your Practice & Cynosure

Keep your practice on top with the latest best-in-class offerings along with dedicated support and turnkey solutions when you partner with Cynosure.

#

Please fill and submit the form below to receive an email containing the asset download link.

#

Please fill and submit the form below to receive an email containing the asset download link.

World-class, dual-wavelength vascular workstation proven safe and effective, including for pediatric use.1

Cynergy™ - Request Info

Cynosure is here to help your practice in any way we can. We have branch offices strategically located throughout Asia and Europe — and we maintain relationships with distributors across five continents. In the United States, our customer service representatives are available to physicians and practitioners 24 hours a day, 7 days a week.